Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Feasability of biowaiver extension to ciprofloxacin

  • At: 2008 FIP Congress in Basel (Switzerland)
  • Type: Poster
  • By: KYRIACOS, Soula (Lebanese American University, Byblos, Lebanon)
  • Co-author(s): Safi, William (Lebanese American University, BYBLOS, Lebanon)
    Boukarim, Chawki (Lebanese American University, BYBLOS, Lebanon)
    Mroueh, Mohamad (Lebanese American University, BYBLOS, Lebanon)
    Bou Maroun, Aline (Lebanese American University, BYBLOS, Lebanon)
    El-Khoury, Ghada (Lebanese American University, BYBLOS, Lebanon)
    Shehayeb, Rabih (Lebanese American University, BYBLOS, Lebanon)
  • Abstract:

    Ciprofloxacin is a widely prescribed synthetic quinolone antiinfective agent. Health professionals are confronted with a wide choice of multi-source generics, imported and locally produced. These generics are available at significant price differences with one generic costing 24 times less than the brand product. Due to the importance of..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses